UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma

Scientific reports, 2021-11, Vol.11 (1), p.22188-22188, Article 22188

2021

Volltextzugriff (PDF)

Successful treatment of intracranial Rosai-Dorfman disease with cytarabine and dexamethasone: case report and review of literature

Annals of hematology, 2020-05, Vol.99 (5), p.1157-1159

2020

Volltextzugriff (PDF)

Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment

Annals of hematology, 2021, Vol.100 (1), p.289-291

2021

Volltextzugriff (PDF)

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology

Journal of hematology and oncology, 2018-03, Vol.11 (1), p.33-33, Article 33

2018

Volltextzugriff (PDF)

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Journal of hematology and oncology, 2020-05, Vol.13 (1), p.48-12, Article 48

2020

Volltextzugriff (PDF)

Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio

Scientific reports, 2020-05, Vol.10 (1), p.7757-7757, Article 7757

2020

Volltextzugriff (PDF)

Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients

Frontiers in microbiology, 2021-04, Vol.12, p.646361-646361

2021

Volltextzugriff (PDF)

Primary extranodal diffuse large B-cell lymphoma in the rituximab era: a single center, retrospective analysis

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.757-764

2022

Volltextzugriff (PDF)

Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract

Neoplasia (New York, N.Y.), 2024-11, Vol.57, p.101048, Article 101048

2024

Volltextzugriff (PDF)

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

Frontiers in oncology, 2021-11, Vol.11

2021

Volltextzugriff (PDF)

Outcome of Cardiac Light-Chain Amyloidosis in the Era of Novel Therapy　― A Single-Center Cohort Study of 227 Patients

Circulation Journal, 2019/03/25, Vol.83(4), pp.775-782

2019

Volltextzugriff (PDF)

Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series

Frontiers in oncology, 2021-12, Vol.11, p.760405-760405

2021

Volltextzugriff (PDF)

Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma

Frontiers in immunology, 2024, Vol.15, p.1365975-1365975

2024

Volltextzugriff (PDF)

Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma

Scientific reports, 2016-12, Vol.6 (1), p.38671-38671, Article 38671

2016

Volltextzugriff (PDF)

Comparison of Different Buffers for Protein Extraction from Formalin-Fixed and Paraffin-Embedded Tissue Specimens

PloS one, 2015-11, Vol.10 (11), p.e0142650-e0142650

2015

Volltextzugriff (PDF)

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China

Cancer medicine (Malden, MA), 2021-02, Vol.10 (3), p.999-1011

2021

Volltextzugriff (PDF)

Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model

Frontiers in oncology, 2022-08, Vol.12, p.955535-955535

2022

Volltextzugriff (PDF)

Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma

BMC cancer, 2021-02, Vol.21 (1), p.183-183, Article 183

2021

Volltextzugriff (PDF)

Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma

European radiology, 2021-04, Vol.31 (4), p.1843-1852

2021

Volltextzugriff (PDF)

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials

Journal of hematology and oncology, 2021-10, Vol.14 (1), p.1-167, Article 167

2021

Volltextzugriff (PDF)

The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first‐line methotrexate treatment: A retrospective study

Cancer medicine (Malden, MA), 2024-05, Vol.13 (9), p.e7193-n/a

2024

Volltextzugriff (PDF)

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL

Frontiers in oncology, 2021-06, Vol.11, p.682436-682436

2021

Volltextzugriff (PDF)

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Blood cancer journal (New York), 2021-08, Vol.11 (8), p.145-145, Article 145

2021

Volltextzugriff (PDF)

The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma

Annals of hematology, 2021-05, Vol.100 (5), p.1251-1260

2021

Volltextzugriff (PDF)

Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies

PloS one, 2014-03, Vol.9 (3), p.e91461-e91461

2014

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(249)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(130)
Humans
(103)
Oncology
(83)
Hematology
(66)
Adult
(57)
Female
(56)
Male
(55)
Middle Aged
(52)
Aged
(45)
Lymphoma
(41)
Prognosis
(39)
Medicine
(28)
Medicine & Public Health
(27)
Young Adult
(26)
Patients
(25)
Retrospective Studies
(25)
Technology
(25)
Physical Sciences
(24)
Science & Technology - Other Topics
(23)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(155)
MEDLINE
(106)
Ingenta
(96)
Journals@Ovid Full Text
(67)
Publisher or Other Site
(52)
Springer Journals
(48)
IngentaConnect Journals
(46)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(34)
Wiley Online Library
(29)
Wiley Online Library
(20)
Elsevier ScienceDirect Journals Complete
(20)
Taylor & Francis Journals
(19)
Taylor & Francis Online
(15)
Taylor & Francis
(15)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(14)
Nature
(8)
Nexis Uni
(3)
SAGE Publications
(3)
IEEE Xplore
(2)
ACM Digital Library
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma

Successful treatment of intracranial Rosai-Dorfman disease with cytarabine and dexamethasone: case report and review of literature

Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio

Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients

Primary extranodal diffuse large B-cell lymphoma in the rituximab era: a single center, retrospective analysis

Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

Outcome of Cardiac Light-Chain Amyloidosis in the Era of Novel Therapy　― A Single-Center Cohort Study of 227 Patients

Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series

Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma

Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma

Comparison of Different Buffers for Protein Extraction from Formalin-Fixed and Paraffin-Embedded Tissue Specimens

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China

Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model

Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma

Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials

The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first‐line methotrexate treatment: A retrospective study

A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma

Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies

Suchergebnisse filtern